Last reviewed · How we verify
Liposomal bupivacaine right injection
Liposomal bupivacaine right injection is a Small molecule drug developed by Prisma Health-Upstate. It is currently FDA-approved. Also known as: Exparel Right.
At a glance
| Generic name | Liposomal bupivacaine right injection |
|---|---|
| Also known as | Exparel Right |
| Sponsor | Prisma Health-Upstate |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Double-Blinded Randomized Controlled Study Investigating the Efficacy of Exparel (Liposomal Bupivacaine) for Postoperative Pain Relief in Mandibular Third Molar Extractions (PHASE4)
- Stopping Opioid Overuse in Obstetrics to Halt Exposure Trial (PHASE4)
- EXPAREL Administered by Infiltration Into the TAP for Prolonged Postsurgical Analgesia in Lower Abdominal Surgeries (PHASE4)
- TAP-patients With Robotic Assisted Lap Prostatectomy (PHASE4)
- EXPAREL Post-tonsillectomy Clinical Trial (PHASE4)
- Pectoralis (II) Block With Liposomal Bupivacaine vs Bupivacaine for Breast Surgery (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Liposomal bupivacaine right injection CI brief — competitive landscape report
- Liposomal bupivacaine right injection updates RSS · CI watch RSS
- Prisma Health-Upstate portfolio CI
Frequently asked questions about Liposomal bupivacaine right injection
What is Liposomal bupivacaine right injection?
Liposomal bupivacaine right injection is a Small molecule drug developed by Prisma Health-Upstate.
Who makes Liposomal bupivacaine right injection?
Liposomal bupivacaine right injection is developed and marketed by Prisma Health-Upstate (see full Prisma Health-Upstate pipeline at /company/prisma-health-upstate).
Is Liposomal bupivacaine right injection also known as anything else?
Liposomal bupivacaine right injection is also known as Exparel Right.
What development phase is Liposomal bupivacaine right injection in?
Liposomal bupivacaine right injection is FDA-approved (marketed).
Related
- Manufacturer: Prisma Health-Upstate — full pipeline
- Also known as: Exparel Right
- Compare: Liposomal bupivacaine right injection vs similar drugs
- Pricing: Liposomal bupivacaine right injection cost, discount & access